Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 136 AL 150

Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives

Cotta Ramusino M, Perini G, Altomare D, Barbarino P, Weidner W, Salvini Porro G, Barkhof F, Rabinovici GD, van der Flier WM, Frisoni GB, Garibotto V, Teipel S, Boccardi M.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2157-2168. doi: 10.1007/s00259-020-05187-x. Epub 2021 Feb 17.

Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity

Chaves S, Várnagy K, Santos MA.

Curr Med Chem. 2021;28(35):7247-7277. doi: 10.2174/0929867328666210218183032.

Exploring new avenues for modifying course of progression of Alzheimer's disease: The rise of natural medicine

Lye S, Aust CE, Griffiths LR, Fernandez F.

J Neurol Sci. 2021 Mar 15;422:117332. doi: 10.1016/j.jns.2021.117332. Epub 2021 Jan 30.

Olfactory impairment in men and mice related to aging and amyloid-induced pathology

Tzeng WY, Figarella K, Garaschuk O.

Pflugers Arch. 2021 May;473(5):805-821. doi: 10.1007/s00424-021-02527-0. Epub 2021 Feb 20.

Aging and Alzheimer's disease connection: Nuclear Tau and lamin A

Gil L, Niño SA, Capdeville G, Jiménez-Capdeville ME.

Neurosci Lett. 2021 Apr 1;749:135741. doi: 10.1016/j.neulet.2021.135741. Epub 2021 Feb 18.

Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer's disease neuropathology

Hossain MF, Wang N, Chen R, Li S, Roy J, Uddin MG, Li Z, Lim LW, Song YQ.

Ageing Res Rev. 2021 May;67:101304. doi: 10.1016/j.arr.2021.101304. Epub 2021 Feb 18.

Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research

Indorewalla KK, O'Connor MK, Budson AE, Guess DiTerlizzi C, Jackson J.

J Alzheimers Dis. 2021;80(3):927-940. doi: 10.3233/JAD-201081.

Role of Hypoxia Inducible Factor-1α in Alzheimer's Disease

Wang YY, Huang ZT, Yuan MH, Jing F, Cai RL, Zou Q, Pu YS, Wang SY, Chen F, Yi WM, Zhang HJ, Cai ZY.

J Alzheimers Dis. 2021;80(3):949-961. doi: 10.3233/JAD-201448.

Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients

Chung M, Rhee HY, Chung WK.

J Alzheimers Dis. 2021;80(3):941-947. doi: 10.3233/JAD-210042.

Neuroinflammation in Alzheimer's disease and beneficial action of luteolin

Delgado A, Cholevas C, Theoharides TC.

Biofactors. 2021 Mar;47(2):207-217. doi: 10.1002/biof.1714. Epub 2021 Feb 21.

The role of exosomal non-coding RNAs in aging-related diseases

Dolati S, Shakouri SK, Dolatkhah N, Yousefi M, Jadidi-Niaragh F, Sanaie S.

Biofactors. 2021 May;47(3):292-310. doi: 10.1002/biof.1715. Epub 2021 Feb 23.

Re-emphasizing early Alzheimer's disease pathology starting in select entorhinal neurons, with a special focus on mitophagy

Kobro-Flatmoen A, Lagartos-Donate MJ, Aman Y, Edison P, Witter MP, Fang EF.

Ageing Res Rev. 2021 May;67:101307. doi: 10.1016/j.arr.2021.101307. Epub 2021 Feb 20.

Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease

Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, Gilbertson LJ, Clark KM, Simpson PV, McManus EJ, Oh JE, Yadavaraj S, King VM, Pillai A, Romero-Ferrando B, Brinkhuis M, Copeland BM, Samad S, Liao S, Schepel JAC.

Alzheimers Res Ther. 2021 Feb 23;13(1):51. doi: 10.1186/s13195-021-00783-x.

Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer's disease

Desale SE, Chinnathambi S.

Cell Commun Signal. 2021 Feb 24;19(1):28. doi: 10.1186/s12964-021-00715-0.

β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease

García-Mejía KA, Custodio-Chablé SJ, Vázquez-Franco JE, Reyes-Maldonado E, Lezama RA.

Alzheimer Dis Assoc Disord. 2021 Jan-Mar 01;35(1):91-97. doi: 10.1097/WAD.0000000000000420.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias